APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
HRG | Histidine-rich glycoprotein | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR3 | Complement factor H-related 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
GBP7 | Guanylate binding protein 7 | Predicted intracellular proteins
| | | | | Tissue enriched |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLGLB2 | Plasminogen-like B2 | Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A10 | Solute carrier family 22, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP2E1 | Cytochrome P450, family 2, subfamily E, polypeptide 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
RDH16 | Retinol dehydrogenase 16 (all-trans) | Predicted membrane proteins
| | | | | Tissue enriched |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Group enriched |
APOF | Apolipoprotein F | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
F7 | Coagulation factor VII (serum prothrombin conversion accelerator) | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | Predicted intracellular proteins
| | | | | Group enriched |
CYP2A13 | Cytochrome P450, family 2, subfamily A, polypeptide 13 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
GDF2 | Growth differentiation factor 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT2B10 | UDP glucuronosyltransferase 2 family, polypeptide B10 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CCL16 | Chemokine (C-C motif) ligand 16 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
F13B | Coagulation factor XIII, B polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C8A | Complement component 8, alpha polypeptide | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A9 | Solute carrier family 22 (organic anion transporter), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HPR | Haptoglobin-related protein | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ORM1 | Orosomucoid 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ITIH3 | Inter-alpha-trypsin inhibitor heavy chain 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FGF21 | Fibroblast growth factor 21 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
INHBC | Inhibin, beta C | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
CFHR1 | Complement factor H-related 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ITIH4 | Inter-alpha-trypsin inhibitor heavy chain family, member 4 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MAT1A | Methionine adenosyltransferase I, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PRAMEF10 | PRAME family member 10 | Predicted intracellular proteins
| | | | | Tissue enriched |
C8B | Complement component 8, beta polypeptide | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC38A4 | Solute carrier family 38, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
INHBE | Inhibin, beta E | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |